| [1] |
Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023[J]. CA: A Cancer Journal for Clinicians, 2023, 73(1): 17-48.
|
| [2] |
赵玉沛，邱江东. 中国腹腔镜胰腺癌根治术: 20年回顾与展望 [J/CD]. 中华普外科手术学杂志（电子版）, 2021, 15(03): 237-240.
|
| [3] |
Rahim MK, Okholm TLH, Jones KB, et al. Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes[J]. Cell, 2023, 186(6): 1127-1143. e18.
|
| [4] |
Dieu-Nosjean MC, Giraldo NA, Kaplon H, et al. Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers [J]. Immunological Reviews, 2016, 271(1): 260-275.
|
| [5] |
Lauss M, Donia M, Svane IM, et al. B Cells and Tertiary Lymphoid Structures: Friends or Foes in Cancer Immunotherapy?[J]. Clinical Cancer Research, 2021, 28(9): 1751-1758.
|
| [6] |
石浩伟，郝少龙，纪宇, 等. 低氧微环境对胰腺癌影响的研究进展 [J/CD]. 中华普外科手术学杂志（电子版）, 2021, 15(03): 351-354.
|
| [7] |
Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade [J]. Science, 2018, 359(6382): 1350-1355.
|
| [8] |
Wellenstein MD, De Visser KE. Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape [J]. Immunity, 2018, 48(3): 399-416.
|
| [9] |
Zou X, Guan C, Gao J, et al. Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy[J]. Frontiers in Immunology, 2023, 14: 1222719.
|
| [10] |
Di Caro G, Bergomas F, Grizzi F, et al. Occurrence of Tertiary Lymphoid Tissue Is Associated with T-Cell Infiltration and Predicts Better Prognosis in Early-Stage Colorectal Cancers[J]. Clinical Cancer Research, 2014, 20(8): 2147-2158.
|
| [11] |
Baratin M, Simon L, Jorquera A, et al. T Cell Zone Resident Macrophages Silently Dispose of Apoptotic Cells in the Lymph Node [J]. Immunity, 2017, 47(2): 349-362. e5.
|
| [12] |
Barone F, Gardner DH, Nayar S, et al. Stromal Fibroblasts in Tertiary Lymphoid Structures: A Novel Target in Chronic Inflammation [J]. Frontiers in Immunology, 2016, 7: 00477.
|
| [13] |
Denton AE, Innocentin S, Carr EJ, et al. Type I interferon induces CXCL13 to support ectopic germinal center formation [J]. Journal of Experimental Medicine, 2019, 216(3): 621-637.
|
| [14] |
Stranford S, Ruddle NH. Follicular dendritic cells, conduits, lymphatic vessels, and high endothelial venules in tertiary lymphoid organs: Parallels with lymph node stroma[J]. Frontiers in Immunology, 2012, 3: 00350.
|
| [15] |
Furtado GC, Marinkovic T, Martin AP, et al. Lymphotoxin beta receptor signaling is required for inflammatory lymphangiogenesis in the thyroid [J]. Proceedings of the National Academy of Sciences, 2007, 104(12): 5026-5031.
|
| [16] |
Martinet L, Garrido I, Filleron T, et al. Human Solid Tumors Contain High Endothelial Venules: Association with T-and B-Lymphocyte Infiltration and Favorable Prognosis in Breast Cancer [J]. Cancer Research, 2011, 71(17): 5678-5687.
|
| [17] |
Posch F, Silina K, Leibl S, et al. Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer[J]. OncoImmunology, 2017, 7(2): e1378844.
|
| [18] |
Siliņa K, Soltermann A, Attar FM, et al. Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma [J]. Cancer Research, 2018, 78(5): 1308-1320.
|
| [19] |
De Silva NS, Klein U. Dynamics of B cells in germinal centres [J]. Nature reviews, Immunology, 2015, 15(3): 137-148.
|
| [20] |
Gunderson AJ, Rajamanickam V, Bui C, et al. Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer [J]. OncoImmunology, 2021, 10(1): e1900635.
|
| [21] |
Gkegka AG, Koukourakis MI, Lambropoulou M, et al. Tumor Microenvironment and Immune Response in Lip Cancer [J]. Cancers, 2023, 15(5): 1478.
|
| [22] |
Gkegka AG, Koukourakis MI, Katotomichelakis M, et al. Cancer Microenvironment Defines Tumor-Infiltrating Lymphocyte Density and Tertiary Lymphoid Structure Formation in Laryngeal Cancer [J]. Head and Neck Pathology, 2022, 17(2): 422-432.
|
| [23] |
Engelhard VH, Rodriguez AB, Mauldin IS, et al. Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity[J]. The Journal of Immunology, 2018, 200(2): 432-442.
|
| [24] |
Hiraoka N, Ino Y, Yamazaki-Itoh R, et al. Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer[J]. British Journal of Cancer, 2015, 112(11): 1782-1790.
|
| [25] |
Dieci MV, Radosevic-Robin N, Fineberg S, et al. Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer [J]. Seminars in Cancer Biology, 2018, 52: 16-25.
|
| [26] |
Fang J, Li X, Ma D, et al. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma[J]. BMC Cancer, 2017, 17(1): 375.
|
| [27] |
Trajkovski G, Ognjenovic L, Karadzov Z, et al. Tertiary Lymphoid Structures in Colorectal Cancers and Their Prognostic Value[J]. Open Access Macedonian Journal of Medical Sciences, 2018, 6(10): 1824-1828.
|
| [28] |
Workel HH, Lubbers JM, Arnold R, et al. A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer [J]. Cancer Immunology Research, 2019, 7(5): 784-796.
|
| [29] |
Tesfaye AA, Kamgar M, Azmi A, et al. The evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunities[J]. Expert Review of Anticancer Therapy, 2017, 18(2): 131-148.
|
| [30] |
Farren MR, Mace TA, Geyer S, et al. Systemic Immune Activity Predicts Overall Survival in Treatment-Naïve Patients with Metastatic Pancreatic Cancer[J]. Clinical Cancer Research, 2016, 22(10): 2565-2574.
|
| [31] |
Drayton DL, Liao S, Mounzer RH, et al. Lymphoid organ development: from ontogeny to neogenesis [J]. Nature Immunology, 2006, 7(4): 344-353.
|
| [32] |
Zou X, Lin X, Cheng H, et al. Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significance[J]. Journal for ImmunoTherapy of Cancer, 2023, 11(6): e006698.
|
| [33] |
Ahmed A, Köhler S, Klotz R, et al. Tertiary lymphoid structures and their association to immune phenotypes and circulatory IL2 levels in pancreatic ductal adenocarcinoma [J]. OncoImmunology, 2022, 11(1): e2027148.
|
| [34] |
Vanhersecke L, Brunet M, Guégan JP, et al. Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression[J]. Nature Cancer, 2021, 2(8): 794-802.
|
| [35] |
Delvecchio FR, Fincham REA, Spear S, et al. Pancreatic Cancer Chemotherapy Is Potentiated by Induction of Tertiary Lymphoid Structures in Mice[J]. Cellular and Molecular Gastroenterology and Hepatology, 2021, 12(5): 1543-1565.
|
| [36] |
Johansson-Percival A, He B, Li ZJ, et al. De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors[J]. Nature Immunology, 2017, 18(11): 1207-1217.
|
| [37] |
Wang X, Li X, Zhao J, et al. Rapid Generation of hPSC‐Derived High Endothelial Venule Organoids with In Vivo Ectopic Lymphoid Tissue Capabilities[J]. Advanced Materials, 2024, 36(15): e2308760.
|
| [38] |
Drayton DL, Ying X, Lee J, et al. Ectopic LTαβ Directs Lymphoid Organ Neogenesis with Concomitant Expression of Peripheral Node Addressin and a HEV-restricted Sulfotransferase[J]. Journal of Experimental Medicine, 2003, 197(9): 1153-1163.
|
| [39] |
Lutz ER, Wu AA, Bigelow E, et al. Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation[J]. Cancer Immunology Research, 2014, 2(7): 616-631.
|